Tumor Infiltrating Lymphocyte Therapy for Ovarian Cancer and Renal Cell Carcinoma

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2015.1075106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Sequencing of T Cell Receptors

Scientific Reports
Multidisciplinary
2015English

Targeted Therapy for Renal Cell Carcinoma

2011English

The Tumor Marker for Renal Cell Carcinoma

Japanese Journal of Urology
Urology
1987English

Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma

Seminars in Nephrology
Nephrology
2020English

Prognostic Impact of Immune Gene Expression Signature and Tumor Infiltrating Immune Cells in Localized Clear Cell Renal Cell Carcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Adjuvant Therapy After Nephrectomy for Renal Cell Carcinoma

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

The Significance of Tumor-Infiltrating Lymphocytes Before and After Neoadjuvant Therapy for Rectal Cancer

Cancer Science
Cancer ResearchMedicineOncology
2018English

Tumour Infiltrating Lymphocyte -Adoptive Cell Therapy: The Emerging Importance of Clonal Neoantigen Targets for Next-Generation Products in Non-Small Cell Lung Cancer

Immuno-Oncology Technology
2019English

CTLA-4 Blockade Boosts the Expansion of Tumor-Reactive CD8+ Tumor-Infiltrating Lymphocytes in Ovarian Cancer

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy